Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001965493 | SCV002221358 | uncertain significance | Early myoclonic encephalopathy | 2021-10-08 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine with tryptophan at codon 968 of the JMJD1C protein (p.Arg968Trp). The arginine residue is moderately conserved and there is a moderate physicochemical difference between arginine and tryptophan. This variant is present in population databases (rs745565258, ExAC 0.009%). This variant has not been reported in the literature in individuals affected with JMJD1C-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004043093 | SCV004068315 | uncertain significance | not specified | 2023-08-21 | criteria provided, single submitter | clinical testing | The c.2902C>T (p.R968W) alteration is located in exon 10 (coding exon 10) of the JMJD1C gene. This alteration results from a C to T substitution at nucleotide position 2902, causing the arginine (R) at amino acid position 968 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |